Understand the source comparison
Peptides and Running Marathon Training Synergy Timing Protocol: Comparison
BPC-157 VEGF upregulation, fibroblast migration, angiogenesis at injury sites Base building, acute injury recovery 2–3× weekly, post-high-load days 4–6 hours Achilles tendinopathy, plantar fasciitis, muscle strains Most effective for localized connective tissu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, fibroblast migration, angiogenesis at injury sites
- Base building, acute injury recovery
- 2–3× weekly, post-high-load days
- 4–6 hours
- Achilles tendinopathy, plantar fasciitis, muscle strains
- Most effective for localized connective tissue injuries; timing relative to training stress is critical. Dose evening after long runs, not morning before
- TB-500
- Actin polymerization, systemic anti-inflammatory, reduced scar tissue formation
- Build phase, peak mileage weeks
- 1× weekly mid-week
- ~10 days
- IT band syndrome, generalized overuse inflammation, muscle recovery
- Best choice for whole-body load management during high-mileage weeks; once-weekly dosing maintains stable plasma levels through multiple training sessions
- Ipamorelin/CJC-1295
- Pulsatile GH release, enhanced sleep quality, collagen synthesis optimization
- Peak mileage, taper (recovery prioritization)
- 3× weekly on high-recovery days, dosed before sleep
- Ipamorelin: 2 hrs; CJC-1295: 6–8 days
- Sleep disruption, inadequate recovery between sessions, stress fracture prevention
- Does not heal injuries directly. Optimizes the hormonal environment for repair; most effective when dosed to align GH pulse with deep sleep cycles
- This comparison underscores that effective peptide use in marathon training isn't about picking the 'best' compound. It's about matching peptide pharmacokinetics to training periodization and injury pathology. BPC-157 shines for acute tissue damage during base building; TB-500 addresses cumulative systemic load during build phases; ipamorelin/CJC-1295 optimizes recovery during peak stress weeks.